Mechanical thrombectomy (MT) has emerged as the guideline-based third pillar of optimal stroke treatment alongside professional neurological treatment on stroke units (SU) and intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator [1–7]. This evidence concerns the gene PLAT and Stroke.